Home › Funds › BML Capital Management, LLC › LENZ

BML Capital Management, LLC position in LENZ

LENZ THERAPEUTICS INC · Health Care

BML Capital Management, LLC reported holding 283,114 shares of LENZ (LENZ THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.58% of its reported portfolio and ranking #16 among its reported holdings. BML Capital Management, LLC has disclosed LENZ holdings in 5 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)283.11K sh
Reported value held$1.09M
Portfolio Weight0.58%
First reportedQ1 2024
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BML Capital Management, LLC's LENZ position evolved

BML Capital Management, LLC first disclosed a stake in LENZ in Q1 2024 at 63,916 shares (US$1.4M). Across 5 filings, BML Capital Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 283,114 shares valued at US$1.1M. Notable position changes include a 85% trim in Q4 2024 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 63.92K $1.43M New
Q2 2024 63.92K $1.11M Hold
Q3 2024 60.00K $1.42M Reduce
Q4 2024 9.27K $267.65K Reduce
Q3 2026 283.11K $1.09M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LENZ and 13F data

LENZ (LENZ THERAPEUTICS INC) is a Health Care company. 20 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$20.5M), Versant Venture Management, LLC (US$15.1M), 72 Investment Holdings, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LENZ

All LENZ fund holders →

FAQ

How long has BML Capital Management, LLC held LENZ?

BML Capital Management, LLC has disclosed LENZ holdings in 5 of the last 11 reported quarters, going back to Q1 2024.

What is BML Capital Management, LLC's current position in LENZ?

As of Q3 2026, BML Capital Management, LLC holds 283.11K shares of LENZ (LENZ THERAPEUTICS INC), valued at $1.09M, representing 0.58% of its reported portfolio and ranking #16.

Has BML Capital Management, LLC been buying or selling LENZ?

In the latest 13F filing (Q3 2026), BML Capital Management, LLC newly opened its position in LENZ.

Which other funds hold LENZ?

Other major institutional holders of LENZ include Alpha Wave Global, LP, Versant Venture Management, LLC, 72 Investment Holdings, LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.